Suppr超能文献

基于碳水化合物的药物研发的最新进展和先进技术。

Recent progress and advanced technology in carbohydrate-based drug development.

机构信息

Key Laboratory of Marine Drugs of Ministry of Education, Shandong Provincial Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China.

Key Laboratory of Marine Drugs of Ministry of Education, Shandong Provincial Key Laboratory of Glycoscience and Glycotechnology, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China; Laboratory for Marine Drugs and Bioproducts, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao, 266237, China.

出版信息

Curr Opin Biotechnol. 2021 Jun;69:191-198. doi: 10.1016/j.copbio.2020.12.023. Epub 2021 Jan 30.

Abstract

Carbohydrates, one of the most abundant and widespread biomolecules in nature, play indispensable roles in diverse biological functions, and represent a treasure trove of untapped potential for pharmaceutical applications. Here, we provide a brief overview of carbohydrate-based drug development (CBDD) over the past two decades. More importantly, advanced techniques and methodologies related to CBDD are emerging, including enzymatic synthesis, metabolic engineering, site-specific glycoconjugation, carbohydrate libraries and microarrays as well as carbohydrate-gut microbiome evaluation. These technologies have dramatically accelerated the speed of CBDD. The recently approved drugs and emerging techniques summarized herein will inspire new sights into potential opportunities to discover novel carbohydrate drugs.

摘要

碳水化合物是自然界中最丰富和广泛存在的生物分子之一,在各种生物功能中发挥着不可或缺的作用,并且为药物应用提供了尚未开发的潜在宝库。在这里,我们简要概述了过去二十年中基于碳水化合物的药物开发 (CBDD)。更重要的是,与 CBDD 相关的先进技术和方法正在出现,包括酶合成、代谢工程、定点糖缀合、碳水化合物文库和微阵列以及碳水化合物-肠道微生物组评估。这些技术极大地加快了 CBDD 的速度。本文总结的最近批准的药物和新兴技术将激发新的视角,为发现新型碳水化合物药物提供潜在机会。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验